Basch published in the Journal of Clinical Oncology

November 12, 2018

UNC Lineberger’s Ethan Basch, MD, MSc, professor in the UNC School of Medicine Division of Hematology/Oncology and director of the UNC Lineberger Cancer Outcomes Research Program, was corresponding author of a study designed to assess the feasibility and resource requirements associated with implementing the National Cancer Institute’s Patient-Reported Outcomes Common Terminology Criteria for Adverse Events in a multi-center trial.

UNC Lineberger researchers publish findings in NPJ Breast Cancer

November 6, 2018

UNC Lineberger’s Zhiyuan Hu, PhD, was co-corresponding author of a study published in NPJ Breast Cancer along with UNC Lineberger co-authors Lisa Carey, MD, physician-in-chief of the N.C. Cancer Hospital and the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, and Yan Li, PhD. The study found that elevated expression of 17 immunity-related genes is associated with better outcomes among women with aggressive forms of estrogen receptor–negative breast cancer.

Hingtgen awarded Hettleman Prize

November 2, 2018

UNC Lineberger’s Shawn Hingtgen, PhD, is being honored with a Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty in recognition of his research that is focused on harnessing the potential of stem cells to develop new and better methods for treating terminal cancer.

Major gift, cancer survivors highlights of Blue Ribbon Gala

October 30, 2018

UNC Lineberger’s celebration of its donors, faculty and patients is capped off by a $10 million donation by Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, to support blood cancer research.

Former patient donates $10 million to further blood cancer research at UNC Lineberger

October 29, 2018

Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.